RC1416 Injection

· Nanjing RegeneCore Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for RC1416 Injection, covering 2024-12-02 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Study of RC1416 Injection in COPD [Phase 2]